Print Page | Report Abuse | Sign In | Register
Mayo Clinic Pathology Update 2018
Tell a Friend About This EventTell a Friend

Mayo Clinic Pathology Update 2018: What you need to know about new AJCC staging and WHO classifications

1/25/2018 to 1/27/2018
When: Thursday, January 25, 2018
Where: Mayo Clinic Education Center
5777 East Mayo Boulevard
Phoenix 85054
United States
Contact: CME Department, Mayo Clinic Scottsdale

« Go to Upcoming Event List  

Course Sponsor: Mayo Clinic in Arizona
Course Directors: Dora M. Lam-Himlin, M.D.; Melissa L. Stanton, M.D.; Henry D. Tazelaar, M.D.
Course Website:
Accreditation: Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 19 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is seeking approval to offer 19 Category I CME and Self‐assessment credits toward Part 2 of the ABPath MOC Program.

Target Audience: This course is designed for pathologists, pathologist assistants, pathology fellows and residents, and allied health staff with an interest in diagnostic pathology. It is also intended for surgeons and oncologists with an interest in new pathologic staging criteria.

Description: Dr. Mahul Amin, editor of the 8th edition of the AJCC Cancer Staging Manual, joins an elite roster of speakers for this third annual 2.5-day general surgical pathology course. Covering a broad range of subjects in diagnostic pathology, the central themes for this year's course include staging changes found in the 8th edition of the AJCC tumor staging manual, and updates in WHO classification. Organ systems discussed include breast, head and neck, gastrointestinal, pulmonary, soft tissue, gynecologic, genitourinary, endocrine, and hematologic. Presentations will summarize changes to terminology and staging; these lectures also include practical discussion of diagnostic challenges, need-to-know molecular updates, and emerging issues. Attendee participation is encouraged via audience response system and engaging case reviews.